Sbc Medical Group Holdings Inc. (SBC) intrinsic value & 10-year financials
Sbc Medical Group Holdings Inc. (SBC) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 4 fiscal years revenue shrank 5.3% a year to $173.6M, with an average return on invested capital of -176.1%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $5.16
- Market cap
- $531.5M
- Revenue (FY2025)
- $173.6M
- Revenue growth (4-yr CAGR)
- -5.3%
- ROIC (10-yr avg)
- -176.1%
- Free cash flow (FY2025)
- $23.3M
SBC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $173.6M | $51.0M | $0.50 | $23.3M | 38.9% | 40.1% |
| FY2024 | $205.4M | $46.6M | $0.48 | $18.0M | 34.2% | -569.2% |
| FY2023 | $193.5M | $339.8K | $0.42 | -$10.7M | -0.9% | 0.9% |
| FY2022 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
SBC Medical Group Holdings Inc revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
SBC Medical Group Holdings Inc returns on capital have been average, hovering around 11.8% ROIC over the decade.
SBC Medical Group Holdings Inc capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, SBC Medical Group Holdings Inc is modeled at -5.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.90 per share.